Adaptive Biotechnologies ADPT Current ratio

Current ratio at other companies

Biodesix, Inc.BDSX

2.8×+0.7×

Guardant HealthGH

4.7×+0.6×

Natera, Inc.NTRA

3×-0.7×

GeneDx HoldingsWGS

3.1×-0.2×

Personalis, Inc.PSNL

6.6×-0.3×

Myriad GeneticsMYGN

2.4×+0.5×

FAQ

What is Adaptive Biotechnologies's current ratio?

Adaptive Biotechnologies (ADPT) reported current ratio of 3.4× in Q1 2026.

How has Adaptive Biotechnologies's current ratio changed year-over-year?

Adaptive Biotechnologies's current ratio increased by 14.8% year-over-year, from 2.9× to 3.4×.

What is the long-term trend for Adaptive Biotechnologies's current ratio?

Over 5 years (2020 to 2025), Adaptive Biotechnologies's current ratio has grown at a -13.5% compound annual growth rate (CAGR), from 6.9× to 3.3×.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.